Product image
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
21 févr. 2024 08h00 HE | Route 92 Medical, Inc.
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
Stroke Rehabilitation Industry Poised for Growth as Innovations in Virtual Reality and Tele-Rehabilitation Advance
31 janv. 2024 10h33 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Stroke Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Stroke Management Market Poised to Surge from $36.94 Billion to $39.98 Billion in 2024
28 janv. 2024 19h56 HE | Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Stroke Management Global Market Report 2024" report has been added to's offering. The global landscape of stroke management...
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
16 nov. 2023 09h00 HE | Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
14 nov. 2023 09h00 HE | Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
Emergen logo.png
Global Urgent Care Apps Market Size USD 42,960.91 Million in 2032 | Emergen Research
07 nov. 2023 14h00 HE | Emergen Research
Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global urgent care apps market is projected to reach value of USD 42,960.91 Million by 2032, according to a current analysis by Emergen Research....
Neurovascular Devices Market - Global Forecast to 2028: Increasing Incidence of Ischemic Stroke and Cerebral Aneurysms Boosts Demand
18 oct. 2023 05h48 HE | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters),...
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
10 oct. 2023 08h00 HE | electroCore, Inc.
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Subarachnoid Hemorrhage (SAH) “NOVIS” Clinical Trial (n=150) of nVNS for the...
Aviv-Clinic Logo.png
Aviv Clinics Highlights Case Report Showing Hyperbaric Oxygen Therapy Improves Post-Stroke Rehabilitation, Specifically Hand Motor Recovery
02 oct. 2023 13h04 HE | Aviv Clinics
ORLANDO, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy...
Company logo.png
A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients
02 oct. 2023 07h25 HE | Pharmazz, Inc.
Special Protocol Assessment Agreement Reached Between Pharmazz, Inc. and the U.S. Food and Drug Administration for Phase 3 Clinical Trial of Sovateltide